Solangepras
CVN424 is an orally active and selective GPR6 inverse agonist with a Ki of 9.4 nM and an EC50 of 38 nM. CVN424 is brain-penetrant and has the potential for Parkinson disease research[1][2].
Product Specifications
Product Name Alternative
CVN424
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
GPR6
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/cvn424.html
Purity
99.70
Solubility
DMSO : 58.33 mg/mL (ultrasonic)
Smiles
FC1=C(OC2CCN(C3=NC4=C(N=C3N[C@H]5COCC5)CN(CC4)C(C)=O)CC2)C=CC(F)=C1
Molecular Formula
C24H29F2N5O3
Molecular Weight
473.52
Precautions
H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-134661A/CVN424-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-134661A/Solangepras-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
Phase 3
CAS Number
[2254706-21-1]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
